Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer...

by Heeger S, Buechler P, Didinger B, Timke C, Friess H, Nill S, Huber PE, Muenter MW, Krempien R, Herfarth KK, Abdollahi A, Buchler MW, Debus J
Published 2005-10-01